BIOMAT Database Logo BIOMAT Database Logo

[Relationship between glycemic control and visceral adiposity index among the patients with type 2 diabetes mellitus]. 2017

Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.

OBJECTIVE To explore the relationship between glycemic control and visceral adiposity index (VAI) among type 2 diabetes mellitus (T2DM) patients. METHODS A community-based epidemiological field study for patients with T2DM aged ≥ 40 years was conducted in China.Every participant underwent physical examinations, biochemical tests of fasting glucose, glycosylated hemoglobin (HbA1c), total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and so on, and a questionnaire, including anthropometric characteristics, lifestyle, disease history, family history, and medication use. Those participants with HbA1c ≥7.0% were classified as the poorly controlled in our analysis of relationship between glycemic control and VAI. Anthropometric characteristics, lifestyle, and biochemical indexes of the participants were compared among the groups of different VAI levels. Logistic models were applied in multiple analysis adjusting for possible confounders. RESULTS A total of 1 607 patients with T2DM were recruited in our analysis with a mean age of (59.4±8.1) years and an average T2DM duration of (7.0±6.4) years. Among them, 78.3% were on hypoglycemic therapy. The cutoff points of quartiles of VAI were calculated for the males and females, respectively. According to the ascending order of the quartiles of VAI, the participants were divided into four groups, i.e. Q1, Q2, Q3, and Q4. The poor glycemic control rate for these groups were 60.6%, 65.7%, 70.1%, and 71.0%, respectively (Trend χ2=12.20, P<0.001). After adjustment for age, gender, systolic blood pressure (SBP), diastolic blood pressure (DBP), LDL-C, smoking, cardio-cerebral vascular disease (CVD) history, hypoglycemic therapy, T2DM duration, and family history of diabetes, the Logistic regression models showed that the glycemic control rate was significantly associated with VAI levels among the patients with T2DM. Compared with the participants in group Q1, the ORs of poor glycemic control for those in groups Q2, Q3, and Q4 were 1.239 (95%CI 0.918 to 1.672), 1.513 (95%CI 1.117 to 2.050), and 1.535 (95%CI 1.128 to 2.088), respectively (trend P=0.003). With each quartile increase in VAI, the OR of poor glycemic control was 1.162 (95%CI 1.054 to 1.282). CONCLUSIONS The glycemic control among the patients with T2DM is significantly associated with VAI. High level of VAI is an indicator of poor glycemic control.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002681 China A country spanning from central Asia to the Pacific Ocean. Inner Mongolia,Manchuria,People's Republic of China,Sinkiang,Mainland China
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females

Related Publications

Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
Relationship between visceral adiposity index and glycemic and metabolic control in children and adolescents with type 1 diabetes mellitus.
February 2024, Irish journal of medical science,
Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
The Relationship Between Visceral Adiposity Index and Epicardial Adipose Tissue in Patients with Type 2 Diabetes Mellitus.
May 2021, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
Visceral adiposity index in female with type 2 diabetic mellitus and its association with the glycemic control.
January 2019, Diabetes & metabolic syndrome,
Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
Dose-response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese.
January 2022, Frontiers in endocrinology,
Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
Relationship between vitamin D and glycemic control in patients with type 2 diabetes mellitus.
January 2015, International journal of clinical and experimental medicine,
Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
Relationship Between Hematological Parameters and Glycemic Control in Type 2 Diabetes Mellitus Patients.
April 2019, Journal of medical biochemistry,
Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
Correlation of Visceral Adiposity Index with Visceral Fat in Obese Patients with and without Type 2 Diabetes Mellitus.
April 2022, The Journal of the Association of Physicians of India,
Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
Relationship between motivational style and glycemic control in Jordanian patients with type 2 diabetes mellitus.
January 2017, Journal of diabetes,
Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
Glycemic index, glycemic load and their association with glycemic control among patients with type 2 diabetes.
April 2014, European journal of clinical nutrition,
Y Y Cao, and X Tang, and K X Sun, and Z K Liu, and X Xiang, and J Juan, and J Song, and Q Z Duan, and D J Zhaxi, and Y N Hu, and Y F Yang, and M Y Shi, and Y H Tian, and S P Huang, and X F Liu, and N Li, and J Li, and T Wu, and D F Chen, and Y H Hu
The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes.
May 2010, Diabetes care,
Copied contents to your clipboard!